63
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Identification of potential biomarkers for pancreatic ductal adenocarcinoma: a bioinformatics analysis

&
Received 28 Jan 2023, Accepted 10 May 2024, Published online: 21 May 2024

References

  • Batool T, Irshad S, Mahmood K. 2021. Novel pathogenic mutation mapping of ASPM gene in consanguineous pakistani families with primary micro cephaly. Braz J Biol. 83:e246040. doi: 10.1590/1519-6984.246040.
  • Cai H, Shao B, Zhou Y, Chen Z. 2020. High expression of TOP2A in hepatocellular carcinoma is associated with disease progression and poor prognosis. Oncol Lett. 20(5):232. doi: 10.3892/ol.2020.12095.
  • Chandler BC, Moubadder L, Ritter CL, Liu M, Cameron M, Wilder-Romans K, Zhang A, Pesch AM, Michmerhuizen AR, Hirsh N, et al. 2020. TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination. J Clin Invest. 130(2):958–973. doi: 10.1172/JCI130435.
  • Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, Netto GJ, Qin ZS, Kumar S, Manne U, et al. 2022. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia. 25:18–27. doi: 10.1016/j.neo.2022.01.001.
  • Chen Q, Yu D, Zhao Y, Qiu J, Xie Y, Tao M. 2019. Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis. J Cell Biochem. 120(12):19496–19508. doi: 10.1002/jcb.29253.
  • Chen Y, Zhang Y. 2023. CircDLG1 promotes malignant development of non-small cell lung cancer through regulation of the miR-630/CENPF axis. Strahlenther Onkol. 199(2):169–181. doi: 10.1007/s00066-022-01965-8.
  • Dalman MR, Deeter A, Nimishakavi G, Duan ZH. 2012. Fold change and p-value cutoffs significantly alter microarray interpretations. BMC Bioinform. 13(Suppl 2):S11. doi: 10.1186/1471-2105-13-S2-S11.
  • Ding J, Liu Y, Lai Y. 2020. Identifying MMP14 and COL12A1 as a potential combination of prognostic biomarkers in pancreatic ductal adenocarcinoma using integrated bioinformatics analysis. PeerJ. 8:e10419. doi: 10.7717/peerj.10419.
  • Fabbro M, Zhou BB, Takahashi M, Sarcevic B, Lal P, Graham ME, Gabrielli BG, Robinson PJ, Nigg EA, Ono Y, et al. 2005. Cdk1/Erk2-and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis. Dev Cell. 9(4):477–488. doi: 10.1016/j.devcel.2005.09.003.
  • Fäldt Beding A, Larsson P, Helou K, Einbeigi Z, Parris TZ. 2022. Pan-cancer analysis identifies BIRC5 as a prognostic biomarker. BMC Cancer. 22(1):322. doi: 10.1186/s12885-022-09371-0.
  • Frampton AE, Castellano L, Colombo T, Giovannetti E, Krell J, Jacob J, Pellegrino L, Roca-Alonso L, Funel N, Gall TMH, et al. 2014. MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression. Gastroenterology. 146(1):268–277.e18., doi: 10.1053/j.gastro.2013.10.010.
  • Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al. 2013. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 6(269):pl1–pl1. doi: 10.1126/scisignal.2004088.
  • Goldman MJ, Craft B, Hastie M, Repečka K, McDade F, Kamath A, Banerjee A, Luo Y, Rogers D, Brooks AN, et al. 2020. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 38(6):675–678., doi: 10.1038/s41587-020-0546-8.
  • Hauptman N, Jevšinek Skok D, Spasovska E, Boštjančič E, Glavač D. 2019. Genes CEP55, FOXD3, FOXF2, GNAO1, GRIA4, and KCNA5 as potential diagnostic biomarkers in colorectal cancer. BMC Med Genomics. 12(1):54. doi: 10.1186/s12920-019-0501-z.
  • Heberle H, Meirelles GV, da Silva FR, Telles GP, Minghim R. 2015. InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC Bioinform. 16(1):169. doi: 10.1186/s12859-015-0611-3.
  • Huang DW, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4(1):44–57. doi: 10.1038/nprot.2008.211.
  • Jiang J, Azevedo-Pouly ACP, Redis RS, Lee EJ, Gusev Y, Allard D, Sutaria DS, Badawi M, Elgamal OA, Lerner MR, et al. 2016. Globally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinoma. Oncotarget. 7(33):53165–53177., doi: 10.18632/oncotarget.10242.
  • Jiao Y, Li Y, Liu S, Chen Q, Liu Y. 2019. ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer. Onco Targets Ther. 12:4141–4152. doi: 10.2147/OTT.S201675.
  • Jin D, Jiao Y, Ji J, Jiang W, Ni W, Wu Y, Ni R, Lu C, Qu L, Ni H, et al. 2020. Identification of prognostic risk factors for pancreatic cancer using bioinformatics analysis. PeerJ. 8:e9301. doi: 10.7717/peerj.9301.
  • Jing X, Wang XJ, Zhang T, Zhu W, Fang Y, Wu H, Liu X, Ma D, Ji X, Jiang Y, et al. 2019. Cell-cycle-dependent phosphorylation of PRPS1 fuels nucleotide synthesis and promotes tumorigenesis. Cancer Res. 79(18):4650–4664. doi: 10.1158/0008-5472.CAN-18-2486.
  • Ke MJ, Ji LD, Li YX. 2020. Bioinformatics analysis combined with experiments to explore potential prognostic factors for pancreatic cancer. Cancer Cell Int. 20(1):382. doi: 10.1186/s12935-020-01474-7.
  • Li C, Hong Z, Ou M, Zhu X, Zhang L, Yang X. 2021. Integrated miRNA-mRNA expression profiles revealing key molecules in ovarian cancer based on bioinformatics analysis. Biomed Res Int. 2021:6673655. doi: 10.1155/2021/6673655.
  • Li X, Shu K, Wang Z, Ding D. 2019. Prognostic significance of KIF2A and KIF20A expression in human cancer: a systematic review and meta-analysis. Medicine (Baltimore). 98). (46):e18040. doi: 10.1097/MD.0000000000018040.
  • Liu Z, Guan C, Lu C, Liu Y, Ni R, Xiao M, Bian Z. 2018. High NUSAP1 expression predicts poor prognosis in colon cancer. Pathol. Res. Pract. 214(7):968–973.
  • Li L, Zhang JW, Jenkins G, Xie F, Carlson EE, Fridley BL, Bamlet WR, Petersen GM, McWilliams RR, Wang L. 2016. Genetic variations associated with gemcitabine treatment outcome in pancreatic cancer. Pharmacogenet Genomics. 26(12):527–537. doi: 10.1097/FPC.0000000000000241.
  • Lv K, Yang J, Sun J, Guan J. 2019. Identification of key candidate genes for pancreatic cancer by bioinformatics analysis. Exp Ther Med. 18(1):451–458. doi: 10.3892/etm.2019.7619.
  • Ma C, Cui Z, Wang Y, Zhang L, Wen J, Guo H, Li N, Zhang W. 2021. Bioinformatics analysis reveals TSPAN1as a candidate biomarker of progression and prognosis in pancreatic cancer. Bosn J Basic Med Sci. 21(1):47–60. doi: 10.17305/bjbms.2020.5096.
  • Ma Y, Pu Y, Peng L, Luo X, Xu J, Peng Y, Tang X. 2019. Identification of potential hub genes associated with the pathogenesis and prognosis of pancreatic duct adenocarcinoma using bioinformatics meta-analysis of multi-platform datasets. Oncol Lett. 18(6):6741–6751. doi: 10.3892/ol.2019.11042.
  • Morita E, Sandrin V, Chung HY, Morham SG, Gygi SP, Rodesch CK, Sundquist WI. 2007. Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis. Embo J. 26(19):4215–4227. doi: 10.1038/sj.emboj.7601850.
  • Nakamura M, Takano A, Thang PM, Tsevegjav B, Zhu M, Yokose T, Yamashita T, Miyagi Y, Daigo Y. 2020. Characterization of KIF20A as a prognostic biomarker and therapeutic target for different subtypes of breast cancer. Int J Oncol. 57(1):277–288. doi: 10.3892/ijo.2020.5060.
  • Pancreatic cancer - statistics. Cancer.Net. 2022. Retrieved March 2, 2023from https://www.cancer.net/cancer-types/pancreatic-cancer/statistics
  • Pei H, Li L, Fridley BL, Jenkins GD, Kalari KR, Lingle W, Petersen G, Lou Z, Wang L. 2009. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell. 16(3):259–266. doi: 10.1016/j.ccr.2009.07.016.
  • Qiu X, Hou QH, Shi QY, Jiang HX, Qin SY. 2020. Identification of hub prognosis-associated oxidative stress genes in pancreatic cancer using integrated bioinformatics analysis. Front Genet. 11:595361. doi: 10.3389/fgene.2020.595361.
  • Rao GJ,Prasad AS. 2024. Classification of gene expression from RNA-seq data for pancreatic cancer prognosis using ensemble learning. J App Biol Biotech. doi: 10.7324/JABB.2024.171755.
  • Shi H, Xu H, Chai C, Qin Z, Zhou W. 2022. Integrated bioinformatics analysis of potential biomarkers for pancreatic cancer. J Clin Lab Anal. 36(5):e24381. doi: 10.1002/jcla.24381.
  • Tang Z, Kang B, Li C, Chen T, Zhang Z. 2019. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 47(W1):W556–W560. doi: 10.1093/nar/gkz430.
  • Tao F, Qi L, Liu G. 2022. Long intergenic non-protein coding RNA 662 accelerates the progression of gastric cancer through up-regulating centrosomal protein 55 by sponging microRNA-195-5p. Bioengineered. 13(2):3007–3018. doi: 10.1080/21655979.2021.2023978.
  • Tsou A-P, Yang C-W, Huang C-YF, Yu RC-T, Lee Y-CG, Chang C-W, Chen B-R, Chung Y-F, Fann M-J, Chi C-W, et al. 2003. Identification of a novel cell cycle regulated gene, HURP, overexpressed in human hepatocellular carcinoma. Oncogene. 22(2):298–307. doi: 10.1038/sj.onc.1206129.
  • Wang Y, Jin T, Dai X, Xu J. 2016. Lentivirus-mediated knockdown of CEP55 suppresses cell proliferation of breast cancer cells. Biosci Trends. 10(1):67–73. doi: 10.5582/bst.2016.01010.
  • Wang D, Xu W, Huang M, Ma W, Liu Y, Zhou X, Yang Q, Mu K. 2023. CENPF knockdown inhibits adriamycin chemoresistance in triple-negative breast cancer via the Rb-E2F1 axis. Sci Rep. 13(1):1803. doi: 10.1038/s41598-023-28355-z.
  • Wong J, Fang G. 2006. HURP controls spindle dynamics to promote proper interkinetochore tension and efficient kinetochore capture. J Cell Biol. 173(6):879–891. doi: 10.1083/jcb.200511132.
  • Zheng X, Liu X, Zheng H, Wang H, Hong D. 2020. Integrated bioinformatics analysis identified COL11A1 as an immune infiltrate correlated prognosticator in pancreatic adenocarcinoma. Int Immunopharmacol. 90:106982. doi: 10.1016/j.intimp.2020.106982.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.